2015
DOI: 10.2146/ajhp140523
|View full text |Cite
|
Sign up to set email alerts
|

Use and effects of cannabinoids in military veterans with posttraumatic stress disorder

Abstract: While further research into cannabinoid treatment effects on PTSD symptoms is required, the evaluated evidence indicates that substantial numbers of military veterans with PTSD use cannabis or derivative products to control PTSD symptoms, with some patients reporting benefits in terms of reduced anxiety and insomnia and improved coping ability.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(27 citation statements)
references
References 17 publications
0
27
0
Order By: Relevance
“…The finding that increased marijuana use in the presence of elevated PTSD symptoms strongly predicts suicidal ideation, PTSD symptoms, and, especially, suicidal behavior, has important clinical implications. There has been a recent surge in legislative efforts to prescribe medical marijuana for PTSD symptoms in civilians and in military personnel, despite inadequate evidence of efficacy involving small sample non‐randomized control trials, and some evidence that harm outweighs benefits (Betthauser, Pilz, & Vollmer, ; Department of Defense, & Department of Veterans Affairs, ; O'Neil et al, ). In fact, medical marijuana is currently legal in 30 states as well as the District of Columbia and can be prescribed for the treatment of PTSD in the majority of these states.…”
Section: Discussionmentioning
confidence: 99%
“…The finding that increased marijuana use in the presence of elevated PTSD symptoms strongly predicts suicidal ideation, PTSD symptoms, and, especially, suicidal behavior, has important clinical implications. There has been a recent surge in legislative efforts to prescribe medical marijuana for PTSD symptoms in civilians and in military personnel, despite inadequate evidence of efficacy involving small sample non‐randomized control trials, and some evidence that harm outweighs benefits (Betthauser, Pilz, & Vollmer, ; Department of Defense, & Department of Veterans Affairs, ; O'Neil et al, ). In fact, medical marijuana is currently legal in 30 states as well as the District of Columbia and can be prescribed for the treatment of PTSD in the majority of these states.…”
Section: Discussionmentioning
confidence: 99%
“…These 2 synthetic forms of THC have also been shown to have analgesic benefit . ‐ There have been other benefits of THC reported also, including antioxidant and neuroprotective, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), MS, autism, Parkinson's, Tourette's syndrome, Huntington's disease/chorea, depression, posttraumatic stress disorder (PTSD), sickle cell disease pain, traumatic brain injury (TBI), hypothermia, duodenal ulcers, anorexia and cachexia, inflammatory bowel disease, spinal cord injury, antispasmodic, muscle relaxation, and spasticity, antibacterial effects against methicillin‐resistant Staphylococcus aureus (MRSA) strains, anti‐proliferative/pro‐apoptotic against tumor cell lines of multiple organ systems including brain, breast, colon, and blood, psoriasis,…”
Section: The Cannabinoidsmentioning
confidence: 99%
“…This research has focused primarily on a handful of the multitude of medical conditions and symptoms for which the benefits of cannabis have been proclaimed anecdotally, including muscle spasm and chronic pain (Borgelt, Franson, Nussbaum, & Wang, 2013; Harrison, Heritier, Childs, Bostwick, & Dziadzko, 2015), nausea and vomiting (Smith, Azariah, Lavender, Stoner, & Bettiol, 2015), epilepsy (Friedman & Devinsky, 2015), appetite stimulation (Gorter, 1999), cancer (Pacher, 2013), and several psychiatric disorders (e.g., post-traumatic stress disorder, anxiety, depression; Betthauser, Pilz, & Vollmer, 2015; Zlebnik & Cheer, 2016). To date, the quality of evidence supportive of cannabinoid treatment for spasticity and chronic pain has been moderate, whereas only low-quality evidence was available to support its use for nausea and vomiting and for weight gain in patients with HIV/AIDS or cancer (for a review, see Whiting et al, 2015).…”
Section: Promises Of Ediblesmentioning
confidence: 99%